Benjamin P. Levy, MD, John Hopkins Sidney Kimmel Cancer Center

Benjamin Levy, MD, and Estelamari Rodriguez, MD, MPH, reflect on their experience managing real-world patients with uncommon EGFR mutations in non–small cell lung cancer.

Focused discussion on uncommon EGFR mutations in non–small cell lung cancer and concurrent treatment options in this setting.

Expert oncologists discuss RET-driven therapy for select solid tumors.